+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine



Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine



Expert Opinion on PharmacoTherapy 15(16): 2329-2345



Although clozapine (CLZ) is considered the best evidence-based therapeutic option for treatment of resistant schizophrenia patients, a significant proportion of CLZ-treated patients show a partial or inadequate response to treatment, leading to increased healthcare cost and poor quality of life for affected individuals. This paper comprises a review of main research in CLZ augmentation strategies for treatment-refractory schizophrenia, with a focus on research conducted between 1990 and 2014. Databases that were searched include: PubMed, CINAHL, EMBASE PsychINFO, AgeLine and Cochrane Database of Systematic Reviews. Primary search terms were 'clozapine augmentation', 'clozapine and add-on' and 'treatment-resistant schizophrenia', with cross reference to specific agents covered in this article. We reviewed the available evidence on CLZ augmentation with antipsychotics, antidepressants, mood stabilizers and other agents. Many drugs have been evaluated as CLZ add-on therapies without demonstrating convincing efficacy in treating refractory schizophrenia symptoms. More research is needed to better define outcomes in schizophrenia, the topic of treatment-resistance and more well-designed trials are required to establish true efficacy and safety of CLZ augmentation strategies.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051716486

Download citation: RISBibTeXText

PMID: 25284216

DOI: 10.1517/14656566.2014.956082


Related references

Augmentation strategies in patients with schizophrenia who show partial response to clozapine treatment. Turk Psikiyatri Dergisi 25(3): 201-211, 2014

Augmentation of clozapine with agomelatine in partial-responder schizophrenia: a 16-week, open-label, uncontrolled pilot study. Journal of Clinical Psychopharmacology 34(4): 491-494, 2014

Acetyl-L-Carnitine Augmentation of Clozapine in Partial-Responder Schizophrenia: A 12-Week, Open-Label Uncontrolled Preliminary Study. Clinical Neuropharmacology 39(6): 277-280, 2016

Augmentation strategies in clozapine-resistant schizophrenia. Cns Drugs 19(10): 843-872, 2005

Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment. Schizophrenia Research 143(1): 207-214, 2013

Augmentation of Clozapine With Paliperidone in Schizophrenia Patients With Partial Response to Treatment: A Case Series. Turk Psikiyatri Dergisi 27(1): 57-62, 2016

P.3.d.017 Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia patients two case reports and discussion. European Neuropsychopharmacology 24: S530-S531, 2014

Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital. Cns Spectrums 19(5): 403-410, 2014

Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia. Clinical Neuropharmacology 29(1): 28-33, 2006

Promising use of minocycline augmentation with clozapine in treatment-resistant schizophrenia. Journal of Psychopharmacology 28(7): 707-708, 2014

Successful augmentation of clozapine-resistant treatment of schizophrenia with clonidine. Progress in Neuro-Psychopharmacology and Biological Psychiatry 34(4): 724-725, 2010

Emotion processing in treatment-resistant schizophrenia patients treated with clozapine: An fMRI study. Schizophrenia Research 168(1-2): 377-380, 2015

Topiramate Augmentation in Clozapine-Treated Patients With Schizophrenia. Journal of Clinical Psychopharmacology 30(6): 706-710, 2010

Augmentation of clozapine with paliperidone in treatment-resistant schizophrenia-A case series. Acta Neuropsychiatrica 23(1): 51-53, 2011

Clozapine augmentation with another antipsychotic for treatment-resistant schizophrenia: a meta-analysis. 2007